Am J Perinatol 2003; 20(6): 305-312
DOI: 10.1055/s-2003-42694
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Obstetric Outcomes of Human Immunodeficiency Virus-1-Serodiscordant Couples Following In Vitro Fertilization with Intracytoplasmic Sperm Injection

Jane Cleary-Goldman1 , Joseph E. Peña2 , Melvin H. Thornton II2 , Julian N. Robinson1 , Mary E. D'Alton1 , Mark V. Sauer2
  • 1Division of Maternal-Fetal Medicine, New York Presbyterian Medical Center, College of Physicians and Surgeons, Columbia University, New York, New York
  • 2Division of Reproductive Endocrinology, New York Presbyterian Medical Center, College of Physicians and Surgeons, Columbia University, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Oktober 2003 (online)

ABSTRACT

The objective of this article is to report obstetric outcomes of human immunodeficiency virus-1 (HIV-1)-serodiscordant couples who underwent in vitro fertilization and embryo transfer (IVF-ET) with intracytoplasmic sperm injection (ICSI) at a tertiary care center. We reviewed the outcomes of seronegative women after IVF-ET with ICSI from January 1, 1997 to June 1, 2002. Serodiscordant couples (n = 25) successfully conceived 27 pregnancies delivering 40 neonates (16 singletons, 9 twins, and 2 triplets). The mean gestational age at delivery was 37 0/7 weeks ± 3 6/7 weeks (range 26 0/7 to 41 2/7 weeks). The mean birth weight was 2646 g ± 952 g (range 678 to 4396 g). The cesarean section rate was 70%. Preterm delivery (<37 weeks) occurred in 7 pregnancies, and low birth weight (<2500 g) was observed in 8 pregnancies. There were no HIV-1 seroconversions detected at delivery. One hundred percent of the mothers and offspring were beyond 3 months postpartum and remained seronegative. IVF-ET with ICSI seems safe and effective for serodiscordant couples. Obstetric outcomes are favorable, and HIV-1 infection risk is limited.

REFERENCES

  • 1 Saracco A, Musicco M, Nicolosi A. et al . Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men.  J Acquir Immune Defic Syndr . 1993;  6 497-502
  • 2 Mandelbrot L, Heard I, Henrion-Geant E, Henrion R. Natural conception in HIV-negative women with HIV-infected partners.  Lancet . 1997;  349 850-851
  • 3 Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment.  Fertil Steril . 2002;  77 218-222
  • 4 Semprini A E, Levi-Setti P, Bozzo M. et al . Insemination of HIV-negative women with processed semen of HIV-positive partners.  Lancet . 1992;  340 1317-1319.
  • 5 Loutradis D, Drakakis P, Kallianidis K, Patsoula E, Bletsa R, Michalas S. Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men.  Fertil Steril . 2001;  75 210-212
  • 6 Sauer M V, Chang P L. Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection.  Am J Obstet Gynecol . 2002;  186 627-633
  • 7 ASRM Practice Committee Report. Guidelines on number of embryos transferred. Birmingham, AL: American Society for Reproductive Medicine; November 1999 . 
  • 8 Sauer M V, Chang P L. Posthumous reproduction in a human immunodeficiency virus-discordant couple.  Am J Obstet Gynecol . 2001;  185 252-253
  • 9 Alexander G R, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States?.  Clin Obstet Gynecol . 1998;  41 114-125
  • 10 Nahvi S, Flanigan T, Cu-Uvin S. Processing of semen from human immunodeficiency virus-seropositive men for use in insemination of seronegative women.  Am J Obstet Gynecol . 2001;  184 1048-1049
  • 11 Semprini A E, Levi-Setti P, Ravizza M, Pardi G. Assisted conception to reduce the risk of male-to-female sexual transfer of HIV in serodiscordant couples: an update. Presented at the 1998 Symposium on AIDS in Women, Sao Paulo, Brazil
  • 12 Marina S, Marina F, Alcolea R. et al . Human immunodeficiency virus type 1: serodiscordant couples can bear healthy children after undergoing intrauterine insemination.  Fertil Steril . 1998;  70 35-39
  • 13 Jamieson D J, Schieve L, Duerr A. Semen processing for HIV-discordant couples.  Am J Obstet Gynecol . 2001;  185 1433-1434
  • 14 de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV.  N Engl J Med . 1994;  331 341-346
  • 15 American College of Obstetricians and Gynecologists. Evaluation of Cesarean Delivery. Washington, DC: ACOG; 2000
  • 16 Semprini A E, Ravizza M, Muggiasca M L, Giuntelli S, Fiore S, Pardi G. Paternal HIV infection and transfer of HIV from mother to fetus.  BMJ . 1994;  308 453
  • 17 Kiessling A A. Expression of human immunodeficiency virus long terminal repeat-coupled genes in early cleaving embryos.  J Reprod Immunol . 1998;  41 95-104
  • 18 Kiessling A. Should ART be used to help an HIV-infected man father a child?.  <~>Yes, it's imperative to the safety of the mother and baby. Contemporary OB/GYN . 2000;  45 41-60
  • 19 American College of Obstetricians and Gynecologists. Human Immunodeficiency Virus: Ethical Guidelines for Obstetricians and Gynecologists. Washington, DC: ACOG. 2001
    >